AUA 2021 Prostate Cancer - Results from #20

Viewing 21-40 of 44 articles

AUA 2021: Association Between Disease Indication and Steroid Use and Mineralocorticoid-Related Toxicity of Abiraterone Acetate in Patients With Advanced Prostate Cancer: A Meta-Analysis of Randomized Control Trials

AUA 2021: Design the High-Risk Localized Prostate Cancer Trial: Defining the Endpoints

AUA 2021: Suicidality in Urologic Cancer Patients

AUA 2021: Controversies in the Management of High-Risk Prostate Cancer

AUA 2021: Relationships of Sites and Burden of Metastases With Long-Term Outcomes and Molecular Subtypes in TITAN

AUA 2021: Balancing Efficacy and Toxicity of Docetaxel in Patients with Metastatic Castration-Resistant Prostate Cancer. Results from a Pooled Analysis of Three Prospective Randomized Trials

AUA 2021: Pembrolizumab Plus Olaparib in Patients With Docetaxel-Pretreated Metastatic Castration-Resistant Prostate Cancer (mCRPC): Updated Results From KEYNOTE-365 Cohort A With a Minimum of 11 Months of Follow-Up for All Patients

AUA 2021: Comparison of the Cardiotoxicity of Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data

AUA 2021: Relugolix vs Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer

AUA 2021: Real-World Utilization of Apalutamide and Enzalutamide in non-metastatic Castrate Resistant Prostate Cancer: A Retrospective Study

AUA 2021: Long-Term Follow-up and Prognostic Factor Analysis in Men with mCRPC Who Receive PSMA-Targeted Lutetium-177 (177Lu)

AUA 2021: State-of-the-art Lecture: Personalized Medicine in the Management of Prostate Cancer Across the Patient Care Continuum

AUA 2021: State-of-the-art Lecture: Fear and Anxiety on Active Surveillance for Low Risk Prostate Cancer

AUA 2021: TOAD: Warts and All? Subgroup Analyses Revealing Differential Treatment Effects in the Timing of Androgen Deprivation Trial

AUA 2021: AUA Guidelines: Advanced Prostate Cancer

AUA 2021: Real-World Effectiveness and Treatment Adherence of Apalutamide in Non-Metastatic Castration-Resistant Prostate Cancer Patients

AUA 2021: The Role of Chemotherapy, Treatment Sequencing in mCRPC and Future Directions

AUA 2021: The Role of Immunotherapy and PARP Inhibitors

AUA 2021: Manipulating the Androgen Axis: New Agents in mHSPC and CRPC

AUA 2021: Imaging of Advanced Prostate Cancer and Impact on Cancer Management

1
2
3